George M. Milne Jr - Jan 6, 2022 Form 4 Insider Report for Amylyx Pharmaceuticals, Inc. (AMLX)

Role
Director
Signature
/s/ Joshua B. Cohen, as Attorney in Fact for George Mclean Milne
Stock symbol
AMLX
Transactions as of
Jan 6, 2022
Transactions value $
$499,985
Form type
4
Date filed
1/10/2022, 07:34 PM
Previous filing
Jun 16, 2021
Next filing
Mar 8, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMLX Common Stock Purchase $500K +26.3K +13.49% $19.00 221K Jan 6, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMLX Stock Option (Right to Buy) Award $0 +8.4K $0.00 8.4K Jan 6, 2022 Common Stock 8.4K $19.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest in full on the date of the Corporation's 2022 Annual Stockholders Meeting, subject to the Reporting Person's continuous service to the Issuer through such vesting date.